Description

• General description: With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
• Application: Parteck® SRP 80, a functional, fully synthetic excipient based on polyvinyl alcohol (PVA), provides consistent, sustained drug delivery over long release periods. Due to its optimized particle properties, Parteck® SRP 80 excipient has a high compressibility and high dilution potential as well as reliable in-vitro drug dissolution.
• Features and Benefits: Reliable sustained release profiles of active pharmaceutical ingredients over several hours Suitable for direct compression processes with conventional equipment Resistant to pH- and alcohol-induced dose dumping Superior batch-to-batch consistency and robust performance due to fully synthetic material
• Legal Information: Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany